References
- Giordano VE, Hernandez D, Mota SE, Adabache-Guel TN, et al. Safety of intravitreal quinupristin/dalfopristin in an animal model. Int J Ophthalmol 2016;9:373–378.
- Lundstrom M, Wejde G, Stenevi U, et al. Endophthalmitis after cataract surgery: A nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 2007;114:866–870.
- Patwardhan A, Rao GP, Saha K, et al. Incidence and outcomes evaluation of endophthalmitis management after phacoemulsification and 3-piece silicone intraocular lens implantation over 6 years in a single eye unit. J Cataract Refract Surg 2006;32:1018–1021.
- Kamalarajah S, Silvestri G, Sharma N, et al. Surveillance of endophthalmitis following cataract surgery in the UK. Eye 2004;18:580–587.
- Montan PG, Koranyi G, Setterquist HE, et al. Endophthalmitis after cataract surgery: Risk factors relating to technique and events of the operation and patient history: a retrospective case-control study. Ophthalmology 1998;105:2171–2177.
- Kampougeris G, Antoniadou A, Kavouklis E, et al. Penetration of moxifloxacin into the human aqueous humour after oral administration. Br J Ophthalmol 2005;89:628–631.
- Kunimoto DY, Das T, Sharma S, et al. Microbiologic spectrum and susceptibility of isolates: part I. Post-operative endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol 1999;128:240–242.
- Hans DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:1–17.
- Ozcimen M, Ozcimen S, Sakarya Y, et al. Ocular penetration of intravenously administered colistin in rabbit uveitis model. J Ocul Pharmacol Ther 2014;30:681–685.
- Biswas S, Brunel JM, Dubus JC, et al. Colistin: an update on the antibiotic of the 21st century. Expert Rev anti Infect Ther 2012;10:917–934.
- Hancock RE, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother 1999;43:1317–1323.
- Marmor MF, Fulton AB, Holder GE. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 2009;118:69–77.
- Manzano RP, Peyman GA, Khan P, et al. Testing intravitreal toxicity of bevacizumab (Avastin). Retina 2006;26:257–261.
- Ng EW, Joo MJ, Au Eong KG, et al. Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit. Curr Eye Res 2003;27:387–393.
- Reddy AK, Reddy RR, Paruvelli MR, et al. Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis? Int Ophthalmol 2015;35:37–42.
- Ferencz JR, Assia EI, Diamantstein L, et al. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis. Arch Ophthalmol 1999;117:1023–1027.
- Cam D, Saatci AO, Micili SC, et al. The effect of intravitreal azithromycin on the albino newborn rabbit retina. Open Ophthalmol J 2016;10:12–16.
- Tran TB, Velkov T, Nation RL, et al. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: Are we there yet? Int J Antimicrob Agents 2016;48:592–597.
- European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters Version 6.0. EUCAST. 2016. [Accessed 10 Nov 2016]. http://www.eucast.org
- Trimble MJ, Mlynárčik P, Kolář M, et al. Polymyxin: alternative mechanisms of action and resistance. Cold Spring Harb Perspect Med 2016;6:a025288.
- Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006;6:589–601.
- Grégoire N, Aranzana-Climent V, Magréault S, et al. Clinical pharmacokinetics and pharmacodynamics of colistin. Clin Pharmacokinet 2017;56:1441–1460.
- Samant P, Ramugade S. Successful use of intravitreal and systemic colistin in treating multidrug resistant Pseudomonas aeruginosa post-operative endophthalmitis. Indian J Ophthalmol 2014;62:1167–1170.
- Radhika M, Mithal K, Bawdekar A, et al. Pharmacokinetics of intravitreal antibiotics in endophthalmitis. J Ophthalmic Inflamm Infect 2014;4:22.
- Comer GM, Miller JB, Schneider EW, et al. Intravitreal daptomycin: a safety and efficacy study. Retina 2011;31:1199–1206.
- Aydin E, Kazi AA, Peyman GA, et al. Intravitreal toxicity of moxifloxacin. Retina 2006;26:187–190.
- Kazi AA, Jermak CM, Peyman GA, et al. Intravitreal toxicity of levofloxacin and gatifloxacin. Ophthalmic Surg Lasers Imaging 2006;37:224–229.